These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35478420)

  • 41. Retrospective investigation of antibodies against chikungunya virus (CHIKV) in serum from febrile patients in Mozambique, 2009-2015: Implications for its prevention and control.
    Antonio VS; Amade NA; Muianga AF; Ali S; Monteiro V; Mula F; Chelene I; Oludele J; Chongo I; José A; Augusto O; Gudo ES
    PLoS One; 2019; 14(3):e0213941. PubMed ID: 30897135
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serological and molecular epidemiology of the Dengue, Zika and Chikungunya viruses in a risk area in Brazil.
    Mota ML; Dos Santos Souza Marinho R; Duro RLS; Hunter J; de Menezes IRA; de Lima Silva JMF; Pereira GLT; Sabino EC; Grumach A; Diaz RS; do Socorro Lucena M; Komninakis SV
    BMC Infect Dis; 2021 Jul; 21(1):704. PubMed ID: 34303348
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical and epidemiologic evaluation of a 2020 chikungunya outbreak in Cambodia.
    Rachmat A; Kelly GC; Hontz RD; Supaprom C; Heang V; Hip P; Garcia-Rivera JA; Prom S; Chhea C; Sutherland IW; Corson KS; Letizia AG
    BMC Infect Dis; 2022 Dec; 22(1):949. PubMed ID: 36526991
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enzyme-linked immunosorbent assay using recombinant envelope protein 2 antigen for diagnosis of Chikungunya virus.
    Fumagalli MJ; de Souza WM; Espósito DLA; Silva A; Romeiro MF; Martinez EZ; da Fonseca BAL; Figueiredo LTM
    Virol J; 2018 Jul; 15(1):112. PubMed ID: 30041676
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chikungunya virus RNA and antibody testing at a National Reference Laboratory since the emergence of Chikungunya virus in the Americas.
    Prince HE; Seaton BL; Matud JL; Batterman HJ
    Clin Vaccine Immunol; 2015 Mar; 22(3):291-7. PubMed ID: 25540275
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Robustness of Serologic Investigations for Chikungunya and Mayaro Viruses following Coemergence.
    Fischer C; Bozza F; Merino Merino XJ; Pedroso C; de Oliveira Filho EF; Moreira-Soto A; Schwalb A; de Lamballerie X; Netto EM; Bozza PT; Sarno M; Brites C; Gotuzzo E; Talledo M; Drexler JF
    mSphere; 2020 Feb; 5(1):. PubMed ID: 32024703
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serological Evidence of Exposure to Onyong-Nyong and Chikungunya Viruses in Febrile Patients of Rural Taita-Taveta County and Urban Kibera Informal Settlement in Nairobi, Kenya.
    Masika MM; Korhonen EM; Smura T; Uusitalo R; Ogola J; Mwaengo D; Jääskeläinen AJ; Alburkat H; Gwon YD; Evander M; Anzala O; Vapalahti O; Huhtamo E
    Viruses; 2022 Jun; 14(6):. PubMed ID: 35746757
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epidemiologic and clinical investigations during a chikungunya outbreak in Rio Grande do Norte State, Brazil.
    Monteiro JD; Valverde JG; Morais IC; Souza CRM; Fagundes Neto JC; Melo MF; Nascimento YM; Alves BEB; Medeiros LG; Pereira HWB; Paiva AAP; Teixeira DG; Moura MCBM; Tavares AM; Fernandes JV; Jeronimo SMB; Araújo JMG
    PLoS One; 2020; 15(11):e0241799. PubMed ID: 33216743
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Low chikungunya virus seroprevalence two years after emergence in Fiji.
    Aubry M; Kama M; Henderson AD; Teissier A; Vanhomwegen J; Mariteragi-Helle T; Paoaafaite T; Manuguerra JC; Christi K; Watson CH; Lau CL; Kucharski AJ; Cao-Lormeau VM
    Int J Infect Dis; 2020 Jan; 90():223-225. PubMed ID: 31689529
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of Two Enzyme-Linked Immunosorbent Assay Kits for Chikungunya Virus IgM Using Samples from Deceased Organ and Tissue Donors.
    Prince HE; Altrich ML; Nowicki MJ
    Clin Vaccine Immunol; 2016 Oct; 23(10):825-830. PubMed ID: 27535838
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chikungunya virus; an emerging arbovirus in Pakistan.
    Ali I; Dasti JI
    J Pak Med Assoc; 2018 Feb; 68(2):252-257. PubMed ID: 29479102
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chikungunya virus with E1-A226V mutation causing two outbreaks in 2010, Guangdong, China.
    Wu D; Zhang Y; Zhouhui Q; Kou J; Liang W; Zhang H; Monagin C; Zhang Q; Li W; Zhong H; He J; Li H; Cai S; Ke C; Lin J
    Virol J; 2013 Jun; 10():174. PubMed ID: 23725047
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-Term Persistence of Chikungunya Virus-Associated Manifestations and Anti-Chikungunya Virus Antibody in Southern Thailand: 5 Years After an Outbreak in 2008-2009.
    Ninla-Aesong P; Mitarnun W; Noipha K
    Viral Immunol; 2020 Mar; 33(2):86-93. PubMed ID: 31976828
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dengue and Chikungunya Virus Co-infections: The Inside Story.
    Londhey V; Agrawal S; Vaidya N; Kini S; Shastri JS; Sunil S
    J Assoc Physicians India; 2016 Mar; 64(3):36-40. PubMed ID: 27731556
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Seroprevalence of Dengue Virus, West Nile Virus, Chikungunya Virus, and Zika Virus in International Travelers Attending a Travel and Migration Center in 2015-2017, Southern Italy.
    Loconsole D; Metallo A; De Robertis AL; Morea A; Quarto M; Chironna M
    Vector Borne Zoonotic Dis; 2018 Jun; 18(6):331-334. PubMed ID: 29683399
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Seroprevalence of chikungunya virus infection among HIV-infected adults in French Caribbean Islands of Martinique and Guadeloupe in 2015: A cross-sectional study.
    Curlier E; Fagour L; Herrmann-Storck C; Staelen A; Vingadassalom I; Breurec S; Abel S; Pierre-François S; Jean-Marie J; Laouénan C; Césaire R; Hoen B; Cabié A
    PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009267. PubMed ID: 33836004
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Seroprevalence of Chikungunya in an Asymptomatic Adult Population in North and South Sulawesi, Indonesia.
    A Jalloh M; Artika IM; P Dewi Y; Syafruddin D; Idris I; B B Bernadus J; Telew A; S Purwanto D; D Rosita Y; Antonjaya U; S A Myint K
    Am J Trop Med Hyg; 2023 Feb; 108(2):359-362. PubMed ID: 36535254
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Seroprevalence of chikungunya virus infection in India, 2017: a cross-sectional population-based serosurvey.
    Kumar MS; Kamaraj P; Khan SA; Allam RR; Barde PV; Dwibedi B; Kanungo S; Mohan U; Mohanty SS; Roy S; Sagar V; Savargaonkar D; Tandale BV; Topno RK; Kumar CPG; Sabarinathan R; Kumar VS; Bitragunta S; Grover GS; Lakshmi PVM; Mishra CM; Sadhukhan P; Sahoo PK; Singh SK; Yadav CP; Dinesh ER; Karunakaran T; Govindhasamy C; Rajasekar TD; Jeyakumar A; Suresh A; Augustine D; Kumar PA; Kumar R; Dutta S; Toteja GS; Gupta N; Clapham HE; Mehendale SM; Murhekar MV
    Lancet Microbe; 2021 Jan; 2(1):e41-e47. PubMed ID: 35544228
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Seroprevalence of antibodies against chikungunya virus in Singapore resident adult population.
    Ang LW; Kam YW; Lin C; Krishnan PU; Tay J; Ng LC; James L; Lee VJM; Goh KT; Ng LFP; Lin RTP
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006163. PubMed ID: 29281644
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Seroprevalence of Chikungunya virus in blood donors from Northern and Southeastern Brazil.
    Slavov SN; Otaguiri KK; Bianquini ML; Bitencourt HTO; Chagas MCM; Guerreiro DSS; Figueiredo LTM; Covas DT; Kashima S
    Hematol Transfus Cell Ther; 2018; 40(4):358-362. PubMed ID: 30370414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.